Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

AVIRAVIR
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ATEA PHARMACEUTICALS INC

GOLDMAN SACHS GROUP INC holds 530,856 shares of AVIR (ATEA PHARMACEUTICALS INC), worth $2.5M as of 2026-Q2. The position was decreased (-9.8% shares). AVIR represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$2.5M

Current Shares

530,856

Total Value Change

+$1.4M

Total Shares Change

+218,721

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
530,856
-9.8%
$2.5M0.0%$4.65
0
2026-Q1
Increased
588,463
+24.5%
$3.2M0.0%$4.82
32
2025-Q4
Increased
472,522
+38.9%
$1.7M0.0%$3.55
34
2025-Q3
Increased
340,140
+13.5%
$986,4060.0%$2.92
28
2025-Q2
Increased
299,657
+15.9%
$1.1M0.0%$3.45
29
2025-Q1
Decreased
258,608
-17.1%
$773,2380.0%$2.93
0
2024-Q4
New
312,135
-
$1M0.0%$3.33
35

Other major holders of AVIR: RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used